Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab (NCT02384954) | Altor BioScience | 2015-04-17 |
Track Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.